Background: Epidemiological studies on smoking and atrial fibrillation have been inconsistent, with some studies showing a positive association while others have found no association. It is also unclear whether there is a doseresponse relationship between the number of cigarettes smoked or pack-years and the risk of atrial fibrillation. We conducted a systematic review and meta-analysis to clarify the association. Design: Systematic review and meta-analysis. Methods: We searched the PubMed and Embase databases for studies of smoking and atrial fibrillation up to 20 July 2017. Prospective studies and nested case-control studies within cohort studies reporting adjusted relative risk estimates and 95% confidence intervals (CIs) of atrial fibrillation associated with smoking were included. Summary relative risks (95% CIs) were estimated using a random effects model. Results: Twenty nine prospective studies (22 publications) were included. The summary relative risk was 1.32 (95% CI 1.12-1.56, I 2 ¼ 84%, n ¼ 11 studies) for current smokers, 1.09 (95% CI 1.00-1.18, I 2 ¼ 33%, n ¼ 9) for former smokers and 1.21 (95% CI 1.12-1.31, I 2 ¼ 80%, n ¼ 14) for ever smokers compared to never smokers. Comparing current versus non-current smokers the summary relative risk was 1.33 (95% CI 1.14-1.56, I 2 ¼ 78%, n ¼ 10). The summary relative risk was 1.14 (95% CI 1.10-1.20, I 2 ¼ 0%, n ¼ 3) per 10 cigarettes per day and 1.16 (95% CI 1.09-1.25, I 2 ¼ 49%, n ¼ 2) per 10 pack-years and there was no evidence of a non-linear association for cigarettes per day, P non-linearity ¼ 0.17.
Introduction
Atrial fibrillation is the most common type of arrhythmia and globally an estimated 5 million incident cases occurred in 2010, 1 and the prevalence has been estimated at 33 million in 2015. 2 The prevalence of atrial fibrillation has been projected to increase 2.5-fold in the next 50 years, partly due to an ageing population, but also due to an increased incidence of the disease.
been shown that patients with atrial fibrillation have higher medical costs and lower quality of life 6 than persons without atrial fibrillation. In addition, coronary artery disease patients with atrial fibrillation have a higher risk of myocardial infarction and cardiovascular disease overall compared to coronary artery disease patients without atrial fibrillation. 7 Established or suspected risk factors for atrial fibrillation include age, heart failure, coronary heart disease, hypertension, diabetes, obesity and elevated resting heart rate. [8] [9] [10] [11] [12] Several cohort studies have investigated the association between smoking and atrial fibrillation 8, and several of these have found a positive association; [13] [14] [15] [17] [18] [19] [20] [21] [24] [25] [26] [27] [28] 32 however, the results have been inconsistent, with several studies finding no clear association. 8, 16, 22, 23, 27, [29] [30] [31] 33 Limited statistical power in some studies and differences in the adjustment for confounding factors and categorisation of smoking (e.g. current vs. non-current compared to current vs. never smokers) may have contributed to some of the variation in the results. Although a previous meta-analysis found an increased risk of atrial fibrillation among smokers 34 the analysis did not investigate whether there was a dose-response relationship between the increasing number of cigarettes smoked or pack-years and atrial fibrillation. In addition, twelve studies (6 publications) were either missed or excluded 14, 15, 18, 21, 22, 26 and at least eight studies (seven publications) 23, 24, [30] [31] [32] [33] 35 have since been published. We therefore conducted an up-to-date meta-analysis of smoking and the risk of atrial fibrillation to clarify the dose-response relationship between smoking and atrial fibrillation and to assess potential sources of heterogeneity in the results including the impact of study characteristics such as study quality and adjustment for confounding factors.
Materials and methods

Search strategy and inclusion criteria
We searched the Pubmed and Embase databases up to 20 July 2017 for eligible studies. The search terms are found in the Supplementary material. We followed standard criteria for reporting meta-analyses. 36 In addition, we searched the reference lists of the identified publications for further studies. The search was conducted by DA and SS.
Study selection
We included published prospective cohort studies and nested case-control studies within cohorts that investigated the association between smoking and the risk of atrial fibrillation. Adjusted estimates of the relative risk (RR) (including hazard ratios or incidence rate ratios) had to be available with the 95% confidence intervals (CIs) in the publication. A list of the excluded studies and exclusion reasons can be found in Supplementary  Table 1 .
Data extraction
The following data were extracted from each study: the first author's last name, publication year, country where the study was conducted, study period, sample size, number of cases and participants, smoking exposure and subgroup, RRs and 95% CIs for smoking compared to not smoking and variables adjusted for in the analysis.
Statistical methods
We calculated summary RRs and 95% CIs of atrial fibrillation by smoking status (current, former, or ever vs. never smokers, or current vs. non-current smokers), by cigarettes smoked per day and pack-years using the random-effects model by DerSimonian and Laird, 37 which takes into account both within and betweenstudy variation (heterogeneity). Current smokers refers to smokers who smoked at the time of baseline examination, former smokers refers to participants who smoked previously, but not currently at baseline, and ever smokers includes both current and former smokers. The average of the natural logarithm of the RRs was estimated and the RR from each study was weighted using random effects weights. When studies reported results stratified by sex or other subgroups but not for the overall population the RRs for each subgroup were pooled using a fixed effects model to obtain a RR for the overall study. Linear doseresponse analyses were conducted using the method of Greenland and Longnecker, 38 and study-specific linear trends and 95% CIs were computed from the natural log of the RRs and CIs across categories of cigarettes per day and pack-years. The linear doseresponse analysis was conducted on a continuous scale with an increment of 10 cigarettes smoked per day and per 10 pack-years. For one study reporting on cigarette-years and atrial fibrillation 20 the data were converted to pack-years by dividing the cigarette-years by 20, as one pack of cigarettes contains 20 cigarettes. A potential non-linear association was investigated using restricted cubic splines with three knots at 10%, 50% and 90% percentiles of the distribution, which was combined using multivariate metaanalysis. 39, 40 Heterogeneity between studies was evaluated using Q and I 2 statistics. 41 I 2 is a measure of how much of the heterogeneity is due to between-study variation rather than chance. I 2 values of 25%, 50% and 75% indicate low, moderate and high heterogeneity, respectively. Subgroup analyses stratified by study characteristics such as duration of follow-up, sex, geographical location, number of cases, study quality and by adjustment for confounding factors (age, alcohol, body mass index, height, diabetes, hypertension, blood cholesterol, prevalent coronary heart disease and physical activity) to investigate potential sources of heterogeneity. Study quality was assessed using the Newcastle Ottawa scale, which rates studies according to selection, comparability and outcome assessment, with a score range from 0 to 9. 42 Publication bias was assessed using Egger's test 43 and Begg-Mazumdar's test 44 and by inspection of funnel plots. The statistical analyses were conducted using the software package Stata, version 13.1 software (StataCorp, Texas, USA).
Results
We identified 29 cohort studies (22 publications) 8, that were included in the meta-analysis ( Figure 1 , Table 1 ). One publication included pooled data from seven cohort studies, 21 another publication included data from five cohort studies, 27 and one publication reported on pooled data from two cohort studies combined. 31 Eighteen studies were from Europe, eight studies were from North America, two studies were from Australia and one study was from Japan (Table 1) . Seventeen cohort studies (11 publications, 11 risk estimates) 8, [14] [15] [16] [17] [18] [19] [21] [22] [23] [24] were included in the analysis of current smokers (9240 cases, 388,030 participants), 15 studies (nine publications, nine risk estimates) 8, 14, [16] [17] [18] [19] 21, 23, 24 were included in the analysis of former smokers (8508 cases, 372,229 participants) and 20 studies (14 publications, 14 risk estimates) 8, [13] [14] [15] [16] [17] [18] [19] 21, 23, 24, 26, 29, 32 were included in the analysis of ever smokers (30, 509 cases, 556,613 participants) compared to never smokers and the risk of atrial fibrillation.
The summary RR was 1.32 (95% CI 1.12-1.56, I
2 ¼ 84%, P heterogeneity < 0.0001) for current smokers (Figure 2(a) ), 1.09 (95% CI 1.00-1.18, I 2 ¼ 33%, P heterogeneity ¼ 0.15) for former smokers (Figure 2(b) ) and 1.21 (95% CI 1.12-1.31, I
2 ¼ 80%, P heterogeneity < 0.0001) for ever smokers (Figure 2(c) ). In 10 studies (five publications, nine risk estimates) 25, 27, 28, 30, 31 comparing current versus non-current smokers (10, 355 cases, 159,748 participants) the summary RR was 1.33 (95% CI 1.14-1.56, I
2 ¼ 78%, P heterogeneity < 0.0001, n ¼ 10) (Figure 2(d) ). The summary RR was 1.14 (95% CI 1.10-1.20, I
2 ¼ 0%, P heterogeneity ¼ 0.41, n ¼ 3) per 10 cigarettes per day (Figure 3 Table 2 ). The summary RR was 1.16 (95% CI 1.09-1.25, I
2 ¼ 49%, P heterogeneity ¼ 0.16, n ¼ 2) per 10 pack-years ( Figure 4) . 20, 33 There was no evidence of publication bias with Egger's test or Begg's test for current (P ¼ 0.86 and P ¼ 0.64, respectively), former (P ¼ 0.92 and P ¼ 0.92, respectively) and ever smokers (P ¼ 0.39 and P ¼ 0.16, respectively), but in the analysis of current versus non-current smokers there was some evidence with Egger's test, P ¼ 0.009, although not with Begg's test, P ¼ 0.47 ( Supplementary Figures 1-4) . There was little variation in the summary RRs (95% CIs) when excluding one study at a time in each analysis ( Supplementary Figures 5-8 ).
Subgroup analyses and study quality
For current and ever smokers there were positive associations in many, but not all subgroup analyses, defined by duration of follow-up, geographical location, number of cases, study quality and by adjustment for Figure 1 . Flow-chart of study selection. some, but not all, confounding factors (including age, body mass index, physical activity, diabetes, coronary heart disease) ( Table 2 ). With meta-regression analyses there was little evidence that the results differed between most subgroups. In the subgroup analysis of adjustment for alcohol there was an indication of heterogeneity for current (P heterogeneity ¼ 0.07) and former (P heterogeneity ¼ 0.04) smokers, with positive associations only observed among studies with no such adjustment. For current smokers there was heterogeneity in the subgroup analysis stratified by adjustment for coronary heart disease (P heterogeneity ¼ 0.01), with a stronger association among studies with such adjustment than among studies without such adjustment. The mean (median) study quality scores were 6.9 (7.0) for current smoking, 7.0 (7.0) for former smoking and 6.9 (7.0) for ever smoking.
Discussion
This meta-analysis of prospective studies suggest that current, former and ever smoking is associated with a 32%, 9% and 21% increased risk of developing atrial fibrillation compared to never smokers. In addition, current versus non-current smoking was associated with a 33% increase in the risk, and in dose-response analyses smoking 10 cigarettes per day and 10 pack-years was associated with 14% and 16% increases in the RR of atrial fibrillation, respectively. There was a clear doseresponse relationship between the increasing number of cigarettes smoked per day and the risk of atrial fibrillation and no evidence that the association was non-linear. The strength of the association by smoking status is also consistent with a dose-response relationship as the association was strongest for current smokers, intermediate for ever smokers (current and former smokers combined) and lowest for former smokers. The present systematic review and meta-analysis has some limitations that need to be discussed. Smokers tend to have a less healthy overall lifestyle than nonsmokers, with more abdominal obesity, less physical activity, higher intake of alcohol and unhealthier diets than non-smokers. We found that the results persisted among studies that adjusted for adiposity and physical activity (ever smokers), although no studies adjusted for dietary factors; however, little is known about the relationship between diet and atrial fibrillation. There was some indication of heterogeneity by adjustment for alcohol, with no association among the few studies with such adjustment; however, further studies are needed to clarify if this really is due to adjustment for alcohol or if it is due to chance or a study-specific effect because there were few studies with such adjustment. Residual confounding by other risk factors than those included in the multivariable models of the original studies can also not be ruled out. Although tobacco smoking was self-reported and there may be some measurement errors in the assessment of tobacco smoking, validation studies using urinary cotinine as a reference biomarker have shown high correlations between self-reported smoking status and the biomarker. 45, 46 Misclassification of the outcome is also a possibility; however, in several subgroup analyses we found no significant heterogeneity in the results between studies that used only hospital discharge linkages to identify cases and studies that used multiple sources (self-report, hospital or medical record linkage, electrocardiograms) to identify the cases, with or without outcome adjudication or validation.
There was high heterogeneity in the analysis of current and ever smokers and there was some variation in the results, with a few studies showing no clear relation while others found 50-100% increases in the RR, but we did not find a clear explanation for this heterogeneity in the subgroup analyses. It is possible that different intensities and durations of tobacco smoking could contribute to such heterogeneity, which then might not be captured by a simple analysis of only smoking status. There was little or no heterogeneity observed in the analysis of former smokers as well as in the analysis of cigarettes per day, but there was also a limited number of studies included in the dose-response analysis. Further studies with more in-depth analyses of number of cigarettes per day, duration, pack-years and time since smoking cessation are needed. It is also possible that residual confounding by passive smoking among the never smokers may have diluted an effect of smoking on atrial fibrillation; however, no prospective data on passive smoking and atrial fibrillation were available.
The dose-response relationship between smoking and the risk of atrial fibrillation may suggest that there is an underlying biological relationship that Figure 4 . Pack-years and atrial fibrillation, dose-response per 10 pack-years. 
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n denotes the number of risk estimates.
1 P for heterogeneity within each subgroup.
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P for heterogeneity between subgroups with meta-regression analysis.
3 P for heterogeneity between men and women excluding studies of men and women combined.
could explain the observed association. Tobacco smoking increases the risk of diabetes, 47 chronic obstructive pulmonary disease, 48 coronary heart disease 48 and heart failure, 49 which are risk factors for atrial fibrillation.
27,50-52 Nicotine in cigarettes stimulates sympathetic neurotransmission increasing plasma catecholamine concentrations 53 and thereby leading to increased resting heart rate, blood pressure 54 and an increased risk of hypertension, [55] [56] [57] which again is associated with an increased risk of atrial fibrillation. 12, 58 Nicotine has also been shown to have direct effects on atrial myocyte ion channel conduction, by blocking outward K þ current, which can lead to a delay of ventricular repolarisation or prolongation of the effective refractory period. 59 Cigarette smoking has also been associated with increased atrial fibrosis, which can lead to atrial arrhythmias by slowing electrical impulse conduction in cardiac tissue. 60 A canine model found that nicotine causes downregulation of micro RNAs in atrial fibroblasts and upregulation of transforming growth factors leading to increased collagen production and atrial fibrosis. 61 The current meta-analysis also has some strengths including the prospective design of the included studies (which avoids or reduces biases that may affect retrospective case-control studies such as recall bias and selection bias), the detailed subgroup and sensitivity analyses, the large sample size, as well as the high study quality of the included studies. Our findings have important clinical and public health implications as they provide evidence of a dose-response relationship between the increasing number of cigarettes smoked and the risk of atrial fibrillation, but also evidence of a reduced risk among former smokers compared to current smokers. The findings therefore underscore the importance of avoiding smoking among non-smokers and smoking cessation among current smokers to prevent atrial fibrillation, although further studies are needed to quantify the duration of cessation that is needed before risk is reduced, and if the risk at some point reaches that of never smokers.
Conclusion
This meta-analysis suggests that current, former and ever smokers are at 32%, 9% and 21% increased risk of atrial fibrillation compared to never smokers, and that there is a dose-dependent association between increasing number of cigarettes smoked and packyears and increased risk. Any further studies should include analyses of the number of cigarettes smoked, duration, pack-years and time since smoking cessation in relation to atrial fibrillation and should adjust for more confounding factors.
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